Recent Posts From All Categories

FDA Renews Licenses for Synchrogenix’s GlobalSubmit eCTD Software

The US FDA has renewed its legacy licenses for Synchrogenix’s eCTD review and validation software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year.

FDA Inactivating Drug Listing Records

Last month the Food and Drug Administration (FDA) announced its intention...

Final Guidance Includes eCTD Implementation Date for Promotional Materials Submissions

Final Guidance and Implementation Date The U.S. Food and Drug...

Attending DIA 2019? Come See Us!

DIA is an opportunity to share challenges, strategies, and other insights to advance our common goal of achieving regulatory success. As one of our valued eCTD Summit community members, we hope you’ll schedule a meeting with us or visit our booth #1117, which is sure to be a premium destination at DIA 2019.

Health Canada eCTD Update

Health Canada announced an update to the mandatory use of the electronic Common Technical Document (eCTD) format. As of June 1, 2019, the remainder of Division 8 regulatory activity types (human drugs only) must be submitted in eCTD format.

DIA’s RSIDM 2019: Highlights from the ‘Ask the Regulators’ Sessions

Synchrogenix was well represented at DIA’s Annual Regulatory Submissions, Information, and Document Management (RSIDM) Forum held earlier this month. One of the reasons RSIDM is such a valuable meeting for Regulatory Operations professionals is because it is so well attended by U.S. FDA staff members who participate both as speakers and fellow attendees. We particularly look forward to the “Ask the Regulators” sessions, where FDA representatives answer questions directly from the attendees. Following are highlights from the ‘Ask the Regulators’ sessions.

WebReview – A Simplified eCTD Submission Review Solution

WebReview is a simple, secure solution that works on any operating system and any browser – no installations, no upgrades – just easy anytime, anywhere access. That includes the homes of those working remotely and even the business center at the Bahamian resort where one of your reviewers is vacationing. Gone are the days of being limited by installs, licenses and platform preferences.

FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format

The CDISC Standard for the Exchange of Nonclinical Data (SEND) provides the structure and implementation rules for the submission of computer readable datasets. SEND is one of the required standards for data submission to the U.S. Food and Drug Administration (FDA) and specifies a way to collect and present nonclinical data in a consistent format. The overall package consists of several components, but the focus is on individual study endpoint data which are typically mapped to datasets in domains with several variables in each study dataset.